Adverse transfusion events


Intravenous news: report “The Centers for Disease Control and Prevention (CDC) has launched the first national surveillance system to monitor adverse events in patients who receive blood transfusions. The CDC is encouraging healthcare facilities across the country to enroll in this new surveillance system, which was designed to improve patient safety.

By having a coordinated national network, the CDC can summarize national data to understand better how to prevent adverse transfusion events such as reactions to blood products, medical errors and process problems.

The system, called the Hemovigilance Module, is part of CDC’s National Healthcare Safety Network (NHSN). NHSN is an Internet-based surveillance system that allows healthcare-associated infection data to be tracked and analyzed to allow CDC and healthcare facilities to maximize prevention efforts. The Hemovigilance Module was developed by CDC in collaboration with AABB, an international association representing organizations involved in transfusion and cellular therapies.”

Click here for the full story.


Comments are closed.